Immunomic Therapeutics has filed a notice of an exempt offering of securities to raise $20,900,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Immunomic Therapeutics is raising up to $20,900,000.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Eric Winzer played a…
